NTSAD - NTSAD

Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

NTSAD Annual Virtual Family Conference

The 43rd Annual Family Conference was our largest conference ever with more than 500 attendees, including 190 first-time attendees and more than 130 families and 26 countries represented!

1

Latest News

FDA Listening Session
Summary of Late Onset GM2 FDA Session Read More
Open Position: Research Director
NTSAD is looking to hire a Research Director. Read More
Milestones for Queens GM2 Project
TSHA-101 gene therapy CTA approved in Canada Read More

1
2
3
4

› ‹

NTSAD leads the worldwide fight to treat and cure Tay-Sachs, Canavan, GM1, and Sandhoff diseases by driving research, forging collaboration, and fostering community. Supporting families is the center of everything we do.

Default
Title
Date
Random

Tweets by @ntsad

Login